Literature DB >> 20437087

N-acetylaspartic acid impairs enzymatic antioxidant defenses and enhances hydrogen peroxide concentration in rat brain.

Carolina Didonet Pederzolli1, Caroline Paula Mescka, Alessandra Selinger Magnusson, Kátia Bueno Deckmann, Evelise de Souza Streck, Angela Malysz Sgaravatti, Mirian Bonaldi Sgarbi, Angela T S Wyse, Clovis M D Wannmacher, Moacir Wajner, Carlos S Dutra-Filho.   

Abstract

N-Acetylaspartic acid accumulates in Canavan Disease, a severe inherited neurometabolic disease clinically characterized by severe mental retardation, hypotonia, macrocephaly and generalized tonic and clonic type seizures. Considering that the mechanisms of brain damage in this disease remain poorly understood, in the present study we investigated the in vitro and in vivo effects of N-acetylaspartic acid on the activities of catalase, superoxide dismutase and glutathione peroxidase, as well as on hydrogen peroxide concentration in cerebral cortex of 14-day-old rats. Catalase and glutathione peroxidase activities were significantly inhibited, while hydrogen peroxide concentration was significantly enhanced by N-acetylaspartic acid both in vitro and in vivo. In contrast, superoxide dismutase activity was not altered by N-acetylaspartic acid. Our results clearly show that N-acetylaspartic acid impairs the enzymatic antioxidant defenses in rat brain. This could be involved in the pathophysiological mechanisms responsible for the brain damage observed in patients affected by Canavan Disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20437087     DOI: 10.1007/s11011-010-9202-1

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  33 in total

Review 1.  Biochemistry and molecular biology of Canavan disease.

Authors:  R Matalon; K Michals-Matalon
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

2.  Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRI.

Authors:  C G Janson; S W J McPhee; J Francis; D Shera; M Assadi; A Freese; P Hurh; J Haselgrove; D J Wang; L Bilaniuk; P Leone
Journal:  Neuropediatrics       Date:  2006-08       Impact factor: 1.947

3.  Accumulation of N-acetyl-L-aspartate in the brain of the tremor rat, a mutant exhibiting absence-like seizure and spongiform degeneration in the central nervous system.

Authors:  K Kitada; T Akimitsu; Y Shigematsu; A Kondo; T Maihara; N Yokoi; T Kuramoto; M Sasa; T Serikawa
Journal:  J Neurochem       Date:  2000-06       Impact factor: 5.372

Review 4.  Canavan disease: a white matter disorder.

Authors:  Shalini Kumar; Natalia S Mattan; Jean de Vellis
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2006

5.  The clinical course of Canavan disease.

Authors:  E C Traeger; I Rapin
Journal:  Pediatr Neurol       Date:  1998-03       Impact factor: 3.372

6.  Restricted diffusion in Canavan disease.

Authors:  S G Srikanth; H S Chandrashekar; K Nagarajan; P N Jayakumar
Journal:  Childs Nerv Syst       Date:  2007-01-12       Impact factor: 1.475

7.  Glutathione peroxidase.

Authors:  A Wendel
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

Review 8.  Evidence supporting a role for N-acetyl-L-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review.

Authors:  Morris H Baslow
Journal:  Neurochem Int       Date:  2002-04       Impact factor: 3.921

9.  Epileptic seizures induced by N-acetyl-L-aspartate in rats: in vivo and in vitro studies.

Authors:  T Akimitsu; K Kurisu; R Hanaya; K Iida; Y Kiura; K Arita; H Matsubayashi; K Ishihara; K Kitada; T Serikawa; M Sasa
Journal:  Brain Res       Date:  2000-04-07       Impact factor: 3.252

Review 10.  Canavan disease: a review of recent developments.

Authors:  N Gordon
Journal:  Eur J Paediatr Neurol       Date:  2001       Impact factor: 3.140

View more
  3 in total

1.  In vivo neuroprotective effect of L-carnitine against oxidative stress in maple syrup urine disease.

Authors:  Caroline Mescka; Tarsila Moraes; Andrea Rosa; Priscila Mazzola; Bruna Piccoli; Carlos Jacques; Giovana Dalazen; Juliana Coelho; Marcelo Cortes; Melaine Terra; Carmen Regla Vargas; Carlos S Dutra-Filho
Journal:  Metab Brain Dis       Date:  2011-03-05       Impact factor: 3.584

2.  The natural history of Canavan disease: 23 new cases and comparison with patients from literature.

Authors:  Annette Bley; Jonas Denecke; Alfried Kohlschütter; Gerhard Schön; Sandra Hischke; Philipp Guder; Tatjana Bierhals; Heather Lau; Maja Hempel; Florian S Eichler
Journal:  Orphanet J Rare Dis       Date:  2021-05-19       Impact factor: 4.123

3.  Increasing N-acetylaspartate in the Brain during Postnatal Myelination Does Not Cause the CNS Pathologies of Canavan Disease.

Authors:  Abhilash P Appu; John R Moffett; Peethambaran Arun; Sean Moran; Vikram Nambiar; Jishnu K S Krishnan; Narayanan Puthillathu; Aryan M A Namboodiri
Journal:  Front Mol Neurosci       Date:  2017-06-02       Impact factor: 5.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.